•  
  •  
 

Abstract

ABSTRACT: BACKGROUND: Survivals of sudden cardiac death (SCD) episodes have recurrence rate of 30-50% within two years, with malignant ventricular arrhythmias most often responsible1, 2. The overall survival rate for SCD in USA is 5%. Ninety-five percent of patients suffering their initial event fail to survive to become candidate for secondary prevention1.Because of the wide spread acceptance of implantable cardioverter defibrillator ( ICD ) as a method treating the survivals of SCD, attention has turned to primary prevention 1. Implantable cardioverter-defibrillator (ICD) is highly effective in primary and secondary prevention of SCD due to life threatening ventricular tachycardia (VT). OBJECTIVE: To register and interpret the results of implantation and follow-up of ICD during the period between 2002-2007 in Ibn Al-Bitar hospital. METHODS: Sixty patients with standard indications for ICD; data were pooled from patients history, ECG, Echocardiography, Holter, blood investigation and coronary angiography.75% males and 25% females. After implantation, class III anti-arrhythmic drugs (Amiodarone) were stopped, except for patients with a history of supraventricular tachycardia or recurrent VT. RESULTS: Coronary artery disease (CAD) was the most common presentation of patients for whom implantation was done; coronary artery disease (CAD) 43%, dilated cardiomyopathy (DCM) 26%, and hypertrophic obstructive cardiomyopathy (HOCM) 16%. Sixty-three of them had moderate-severe LV dysfunction (LVEF

Download

Share

COinS